EORTC protocol 18832

Randomized phase III trial comparing surgery with or without prophylactic isolation perfusion for stage I high risk (> 1.5 mm thickness) malignant melanoma of the limbs (Jointly with WHO and NAPG)
Trial StatusAll trial activities ended
DatesDate of activation: 15-Mar-84
Closed on : 20-Apr-94
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size226
Number of steps1
Drug
Study Staff
Type of cancerMelanoma
Participating GroupsEORTC Melanoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section